Skip to content
Home / Companies / AUPH AUP
Aurinia Pharmaceuticals Inc. (AUPH) XNAS PHARMACEUTICAL PREPARATIONS Net insider buying (90d)
Latest AUPH Insider Trades
About Aurinia Pharmaceuticals Inc. (AUPH) Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Headquarters EDMONTON, A0
Employees 128
Listed 2009
Exchange XNAS https://www.auriniapharma.com SEC filings for AUPH on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market purchase 5 814,606 $12.46M Open-market sale 1 20,975 $356K Grant or award 4 95,724
AUPH Insider Transactions (Form 4) 58 34 Form 4 filings on record, the earliest from Nov 12, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 21, 2026 SR Stephen P. Robertson - Officer Open-market sale Common Stock 20,975
Recent AUPH Form 8-K Filings 5
Recent AUPH Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 21, 2026 Stephen P. Robertson Officer 47,000 $719K View on EDGAR Jun 5, 2026 - -
AUPH Insider Trading - FAQ
What is the latest insider trade for AUPH? Aurinia Pharmaceuticals Inc. (AUPH) had 6 insider filings in the last 90 days, with the most recent on 2026-08-26. The full record for AUPH runs to 34 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AUPH stock? 5 insider purchases of AUPH were filed in the last 90 days, totaling $12.46M.
How many insiders are selling AUPH stock? 1 insider sale of AUPH was filed in the last 90 days, totaling $356K.
Where can I see AUPH SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks AUPH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AUPH insider buys? Create a free InsiderAlpha account and press Watch on this page to add AUPH to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track AUPH insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Open-market purchase $4.02M
KT Kevin Tang - Officer Open-market purchase $5.25M
Jun 1, 2026
KT Kevin Tang - Officer Open-market purchase $2K
Jun 1, 2026
KT Kevin Tang - Officer Open-market purchase $3.15M
Jun 2, 2026
Market cap $2.17B
P/E ratio 7.10
Dividend yield -
Average volume 1.44M
52 week high $19.25
52 week low $10.34
Today's high $16.47
Today's low $16.26
Open $16.44
Volume 630.9K
Previous close $16.48
Shares outstanding 133.05M Market cap
$2.17B
128 employees
AUPH Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
97% Buying 3% Selling
5 insider purchases totaling $12.46M against 1 sale totaling $356K.
Most-Active AUPH Insiders - Last 90 Days 10 Other acquisition / disposition 1 10,000
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jun 4, 2026 CJ Craig A. Johnson - Director Grant or award Director Stock Option (right to buy) 23,931 $0.00 -
Jun 4, 2026 KG Kathleen Goetz - Director Grant or award Director Stock Option (right to buy) 23,931 $0.00 -
Jun 4, 2026 TN Tina Susan Nova - Director Grant or award Director Stock Option (right to buy) 23,931 $0.00 -
Jun 4, 2026 JB Jeffrey Allen Bailey - Director Grant or award Director Stock Option (right to buy) 23,931 $0.00 -
May 29, 2026 KT Kevin Tang - Officer Open-market purchase Common Shares 2,299 $15.35 $35K
May 29, 2026 KT Kevin Tang - Officer Open-market purchase Common Shares 262,682 $15.31 $4.02M
Jun 1, 2026 KT Kevin Tang - Officer Open-market purchase Common Shares 343,521 $15.28 $5.25M
Jun 1, 2026 KT Kevin Tang - Officer Open-market purchase Common Shares 99 $15.34 $2K
Jun 2, 2026 KT Kevin Tang - Officer Open-market purchase Common Shares 206,005 $15.28 $3.15M
Jun 2, 2026 KT Kevin Tang - Officer Other Short Put Options (potential obligation to buy) 10,000 $1.65 $17K
May 18, 2026 MH Michael S. Hearne - Officer Grant or award Employee Stock Option (right to buy) 70,230 $0.00 -
May 18, 2026 RC Ryan Cole - Officer Grant or award Common Stock 116,144 $0.00 -
May 18, 2026 RC Ryan Cole - Officer Grant or award Employee Stock Option (right to buy) 70,230 $0.00 -
Mar 6, 2026 GK Greg Keenan - Officer Tax withholding / forfeiture Common Stock 8,069 $14.32 $116K
Mar 2, 2026 KT Kevin Tang Open-market purchase Common Shares 115,792 $14.21 $1.65M
Mar 3, 2026 KT Kevin Tang Open-market purchase Common Shares 184,208 $14.22 $2.62M
Feb 27, 2026 KT Kevin Tang Open-market purchase Common Shares 300,000 $13.90 $4.17M
Feb 27, 2026 KT Kevin Tang Open-market purchase Common Shares 214,839 $14.12 $3.03M
Feb 27, 2026 KT Kevin Tang Open-market purchase Common Shares 1,600 $14.38 $23K
Mar 2, 2026 KT Kevin Tang Open-market purchase Common Shares 83,561 $14.33 $1.20M
Mar 2, 2026 JM Joseph M. Miller - Officer Tax withholding / forfeiture Common Stock 37,511 $14.21 $533K
Feb 27, 2026 JM Joseph M. Miller - Officer Grant or award Employee Stock Option (right to buy) 95,700 $0.00 -
Feb 27, 2026 PG Peter Greenleaf - Officer Grant or award Common Stock 196,403 $0.00 -
Mar 2, 2026 PG Peter Greenleaf - Officer Tax withholding / forfeiture Common Stock 100,890 $14.21 $1.43M
Feb 27, 2026 PG Peter Greenleaf - Officer Grant or award Employee Stock Option (right to buy) 328,424 $0.00 -
Feb 27, 2026 GK Greg Keenan - Officer Grant or award Common Stock 40,586 $0.00 -
Feb 27, 2026 GK Greg Keenan - Officer Grant or award Employee Stock Option (right to buy) 67,870 $0.00 -
Mar 2, 2026 SR Stephen P. Robertson - Officer Tax withholding / forfeiture Common Stock 36,525 $14.21 $519K
Feb 27, 2026 SR Stephen P. Robertson - Officer Grant or award Employee Stock Option (right to buy) 98,813 $0.00 -
Feb 20, 2026 PG Peter Greenleaf - Officer Tax withholding / forfeiture Common Stock 100,171 $14.40 $1.44M
Feb 20, 2026 JM Joseph M. Miller - Officer Tax withholding / forfeiture Common Stock 32,424 $14.40 $467K
Feb 20, 2026 SR Stephen P. Robertson - Officer Tax withholding / forfeiture Common Stock 34,638 $14.40 $499K
Feb 2, 2026 GK Greg Keenan - Officer Tax withholding / forfeiture Common Stock 11,552 $14.53 $168K
Nov 21, 2025 CJ Craig A. Johnson - Director Tax withholding / forfeiture Common Shares 6,039 $15.68 $95K
Nov 21, 2025 JB Jeffrey Allen Bailey - Director Tax withholding / forfeiture Common Shares 2,716 $15.68 $43K
Aug 1, 2025 KT Kevin Tang Open-market purchase Common Shares 1,000,000 $10.12 $10.12M
Aug 4, 2025 KT Kevin Tang Open-market purchase Common Shares 100,000 $11.34 $1.13M
Aug 5, 2025 KT Kevin Tang Open-market purchase Common Shares 200,000 $11.68 $2.34M
Aug 1, 2025 GK Greg Keenan - Officer Open-market sale Common Stock 20,000 $10.50 $210K
May 16, 2025 TN Tina Susan Nova - Director Grant or award Director Stock Option (right to buy) 63,724 $0.00 -
Dec 5, 2024 KT Kevin Tang Open-market purchase Common Shares 300,000 $8.91 $2.67M
Dec 6, 2024 KT Kevin Tang Open-market purchase Common Shares 400,000 $9.01 $3.60M
Dec 9, 2024 KT Kevin Tang Open-market purchase Common Shares 500,000 $9.09 $4.54M
Nov 21, 2024 CJ Craig A. Johnson - Director Grant or award Common Shares 20,631 $0.00 -
Nov 21, 2024 CJ Craig A. Johnson - Director Grant or award Director Stock Option (right to buy) 31,688 $0.00 -
Nov 21, 2024 DJ David R.W. Jayne - Director Grant or award Common Shares 12,135 $0.00 -
Nov 21, 2024 DJ David R.W. Jayne - Director Grant or award Director Stock Option (right to buy) 18,641 $0.00 -
Nov 21, 2024 JB Jeffrey Allen Bailey - Director Grant or award Director Stock Option (right to buy) 18,641 $0.00 -
AVT $CORT
CORCEPT THERAPEUTICS INC
Kevin Tang - OfficerOpen-market purchase$35K
